Promega corporation:1107424 TN17013858 luminescence assay systems have become increasingly used in biology and medical research laboratories in addition to fluorescence and chemiluminescence detection…

Ended Awarded

Contract number
HHSN26800002
Awardee
Awarding agency
Obligated
$7,968

Award facts

Contract value 100% obligated
$7,967.65 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Madison, WI 53711, USA

Award details come from SAM.gov/FPDS.

Description

Promega corporation:1107424 TN17013858 luminescence assay systems have become increasingly used in biology and medical research laboratories in addition to fluorescence and chemiluminescence detection strategies quote no. 103294

Quick answers

Who was awarded contract HHSN26800002?

HHSN26800002 was awarded to Promega Corporation by National Heart Lung and Blood Institute (National Institutes of Health) on April 14, 2017.

How much is contract HHSN26800002 worth?

The government has obligated $7,968 on HHSN26800002.

Is contract HHSN26800002 an order under another contract?

Yes. HHSN26800002 is a BPA call under HHSN263201500038B, a blanket purchase agreement.

Was contract HHSN26800002 competed?

The extent of competition for HHSN26800002 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award